Annual report [Section 13 and 15(d), not S-K Item 405]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)

v3.25.0.1
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2024
Disclosure Text Block [Abstract]  
Schedule of Inventories
The following table presents the detail of our Inventories on the Statements of Consolidated Financial Position:
December 31,
(In millions) 2024 2023
Product inventories
Finished and semi-finished goods $ 2,393  $ 2,573 
Raw materials 2,208  1,476 
Total product inventories 4,601  4,049 
Manufacturing supplies and critical spares 493  411 
Inventories $ 5,094  $ 4,460 
Supplier Finance Program
The following is a roll-forward of our obligations related to supply chain finance programs classified in Other current liabilities:
(In millions) 2024
Supply chain finance obligations as of January 1 $ 21 
Invoices confirmed during the year 230 
Confirmed invoices paid during the year (222)
Supply chain finance obligations as of December 31 $ 29 
The following is a roll-forward of our obligations related to supply chain finance programs classified in Accounts payable:
(In millions) 2024
Supply chain finance obligations as of January 1 $ 91 
Invoices confirmed during the year 375 
Confirmed invoices paid during the year (390)
Supply chain finance obligations as of December 31 $ 76 
Schedule of Restructuring Reserve by Type of Cost
The following table represents a reconciliation of our accrued liabilities related to the Weirton indefinite idle:
(In millions) Employee-Related Costs Exit Costs Asset Impairment Total
Balance as of December 31, 2023 $ —  $ —  $ —  $ — 
Costs incurred1
82  49  79  210
Cash payments (26) (34) —  (60)
Non-cash —  —  (79) (79)
Balance as of December 31, 2024 $ 56  $ 15  $ —  $ 71 
1 Of the $210 million of cost incurred, $129 million was recorded in Restructuring and other charges, $79 million was recorded in Asset impairments and $2 million was recorded in Net periodic benefit credits other than service cost component.
Schedule of Cash Flow, Supplemental Disclosures
A reconciliation of capital additions to cash paid for capital expenditures is as follows:
Year Ended December 31,
(In millions) 2024 2023 2022
Capital additions $ 817  $ 785  $ 1,033 
Less:
Non-cash accruals (47) (13) 35 
Equipment financed with seller 72  59  — 
Right-of-use assets - finance leases 97  93  55 
Cash paid for capital expenditures including deposits $ 695  $ 646  $ 943 
Additionally, included within Other investing activities on the Statements of Consolidated Cash Flows are grant reimbursements related to governmental funded capital projects. For the years ended December 31, 2024, 2023 and 2022, grant reimbursements were $8 million, $13 million and $27 million, respectively.
Cash payments (receipts) for interest and income taxes are as follows:
Year Ended December 31,
(In millions) 2024 2023 2022
Income taxes paid $ 17  $ 94  $ 334 
Income tax refunds (47) (205) (3)
Interest paid on debt obligations net of capitalized interest1
255  256  249 
1 Capitalized interest was $15 million, $12 million and $9 million for the years ended December 31, 2024, 2023 and 2022, respectively.
Schedule of Noncash or Part Noncash Acquisitions
Other non-cash investing and financing activities are as follows:
Year Ended December 31,
(In millions) 2024 2023 2022
Fair value of common shares issued as part of consideration in connection with the Stelco Acquisition $ 343  $ —  $ — 
1.500% 2025 Convertible Senior Notes redemption —  —  25